
Please try another search
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Name | Age | Since | Title |
---|---|---|---|
Zhongliang Yu | 56 | 2016 | Non-Executive Director |
Chuncheng Wang | 58 | 2014 | Non-Executive Chairman |
Xiangming Li | 56 | 2012 | Executive Vice Chairman of the Board |
Kejian Zhang | 69 | 2016 | Independent Non-Executive Director |
Ruifang Jiao | 47 | 2022 | Non-Executive Director |
Wei Guo | 47 | 2023 | Non-Executive Director |
Yongqiang Sun | 55 | 2023 | Non-Executive Director |
Chuan Guo | 57 | 2024 | Non-Executive Director |
Xiaosong Bai | 54 | 2022 | Executive Chairman of the Board |
Kai Qiu | 56 | - | VP & Chairman of China Resources Boya |
Ran Tao | 60 | 2021 | VP & Executive Director |
Rong Deng | 47 | 2023 | CFO & Executive Director |
Tingmei Fu | 59 | 2016 | Independent Non-Executive Director |
Mun Wai Chiu | 55 | 2025 | Independent Non-Executive Director |
Luwen Shi | 61 | 2025 | Independent Non-Executive Director |
Wang Yuhang | 52 | 2025 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review